Last group is CN-high/p53-abnormal: This subgroup includes tumors with extensive CN alterations and p53 abnormalities, often corresponding to the more aggressive type II endometrial carcinomas, such as serous and clear cell subtypes [11]. This evidence concerns the gene TP53 and endometrial carcinoma.